-
Je něco špatně v tomto záznamu ?
Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement
L. Knybel, J. Cvek, T. Blazek, A. Binarova, T. Parackova, K. Resova
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
FNOs/2021
Ministerstvo Zdravotnictví Ceské Republiky
FNOs/2021
Ministerstvo Zdravotnictví Ceské Republiky
NLK
BioMedCentral
od 2006-12-01
BioMedCentral Open Access
od 2006
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
Springer Nature OA/Free Journals
od 2006-12-01
- MeSH
- celková dávka radioterapie MeSH
- hypofrakcionace při ozařování MeSH
- lidé MeSH
- nádory prostaty diagnostické zobrazování patologie radioterapie MeSH
- plánování radioterapie pomocí počítače metody MeSH
- počítačová rentgenová tomografie metody MeSH
- počítačové zpracování obrazu metody MeSH
- pohyb MeSH
- protézy a implantáty * MeSH
- radioterapie řízená obrazem metody MeSH
- radioterapie s modulovanou intenzitou metody MeSH
- zaměřovací značky pro radioterapii statistika a číselné údaje MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: To report prostate deformation during treatment, based on an analysis of fiducial marker positional differences in a large sample. MATERIAL AND METHODS: This study included 144 patients treated with prostate stereotactic body radiation therapy after implantation in each of 4 gold fiducial markers (FMs), which were located and numbered consistently. The center of mass of the FMs was recorded for every pair of X-ray images taken during treatment. The distance between each pair of fiducials in the live X-ray images is calculated and compared with the respective distances as determined in the CT volume. The RBE is the difference between these distances. Mean RBE and intrafraction and interfraction RBE were evaluated. The intrafraction and intefraction RBE variability were defined as the standard deviation, respectively, of all RBE during 1 treatment fraction and of the mean daily RBE over the whole treatment course. RESULTS: We analyzed 720 treatment fractions comprising 24,453 orthogonal X-ray image acquisitions. We observed a trend to higher RBE related to FM4 (apex) during treatment. The fiducial marker in the prostate apex could not be used in 16% of observations, in which RBE was > 2.5 mm. The mean RBEavg was 0.93 ± 0.39 mm (range 0.32-1.79 mm) over the 5 fractions. The RBEavg was significantly lower for the first and second fraction compared with the others (P < .001). The interfraction variability of RBEavg was 0.26 ± 0.16 mm (range 0.04-0.74 mm). The mean intrafraction variability of all FMs was 0.45 ± 0.25 mm. The highest Pearson correlation coefficient was observed between FM2 and FM3 (middle left and right prostate) (R = 0.78; P < .001). Every combination with FM4 yielded lower coefficients (range 0.66-0.71; P < .001), indicating different deformation of the prostate apex. CONCLUSIONS: Ideally, prostate deformation is generally small, but it is very sensitive to rectal and bladder filling. We observed RBE up to 11.3 mm. The overall correlation between FMs was affected by shifts of individual fiducials, indicating that the prostate is not a "rigid" organ. Systematic change of RBE average between subsequent fractions indicates a systematic change in prostate shape.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011736
- 003
- CZ-PrNML
- 005
- 20220506130754.0
- 007
- ta
- 008
- 220425s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13014-021-01958-4 $2 doi
- 035 __
- $a (PubMed)34876173
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Knybel, Lukas $u Department of Oncology, University Hospital Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic
- 245 10
- $a Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement / $c L. Knybel, J. Cvek, T. Blazek, A. Binarova, T. Parackova, K. Resova
- 520 9_
- $a BACKGROUND: To report prostate deformation during treatment, based on an analysis of fiducial marker positional differences in a large sample. MATERIAL AND METHODS: This study included 144 patients treated with prostate stereotactic body radiation therapy after implantation in each of 4 gold fiducial markers (FMs), which were located and numbered consistently. The center of mass of the FMs was recorded for every pair of X-ray images taken during treatment. The distance between each pair of fiducials in the live X-ray images is calculated and compared with the respective distances as determined in the CT volume. The RBE is the difference between these distances. Mean RBE and intrafraction and interfraction RBE were evaluated. The intrafraction and intefraction RBE variability were defined as the standard deviation, respectively, of all RBE during 1 treatment fraction and of the mean daily RBE over the whole treatment course. RESULTS: We analyzed 720 treatment fractions comprising 24,453 orthogonal X-ray image acquisitions. We observed a trend to higher RBE related to FM4 (apex) during treatment. The fiducial marker in the prostate apex could not be used in 16% of observations, in which RBE was > 2.5 mm. The mean RBEavg was 0.93 ± 0.39 mm (range 0.32-1.79 mm) over the 5 fractions. The RBEavg was significantly lower for the first and second fraction compared with the others (P < .001). The interfraction variability of RBEavg was 0.26 ± 0.16 mm (range 0.04-0.74 mm). The mean intrafraction variability of all FMs was 0.45 ± 0.25 mm. The highest Pearson correlation coefficient was observed between FM2 and FM3 (middle left and right prostate) (R = 0.78; P < .001). Every combination with FM4 yielded lower coefficients (range 0.66-0.71; P < .001), indicating different deformation of the prostate apex. CONCLUSIONS: Ideally, prostate deformation is generally small, but it is very sensitive to rectal and bladder filling. We observed RBE up to 11.3 mm. The overall correlation between FMs was affected by shifts of individual fiducials, indicating that the prostate is not a "rigid" organ. Systematic change of RBE average between subsequent fractions indicates a systematic change in prostate shape.
- 650 _2
- $a zaměřovací značky pro radioterapii $x statistika a číselné údaje $7 D057918
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a počítačové zpracování obrazu $x metody $7 D007091
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pohyb $7 D009068
- 650 _2
- $a nádory prostaty $x diagnostické zobrazování $x patologie $x radioterapie $7 D011471
- 650 12
- $a protézy a implantáty $7 D019736
- 650 _2
- $a hypofrakcionace při ozařování $7 D000069473
- 650 _2
- $a celková dávka radioterapie $7 D011879
- 650 _2
- $a plánování radioterapie pomocí počítače $x metody $7 D011880
- 650 _2
- $a radioterapie řízená obrazem $x metody $7 D061089
- 650 _2
- $a radioterapie s modulovanou intenzitou $x metody $7 D050397
- 650 _2
- $a počítačová rentgenová tomografie $x metody $7 D014057
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cvek, Jakub $u Department of Oncology, University Hospital Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic. jakub.cvek@fno.cz $1 https://orcid.org/0000000315791792
- 700 1_
- $a Blazek, Tomas $u Department of Oncology, University Hospital Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic
- 700 1_
- $a Binarova, Andrea $u Department of Oncology, University Hospital Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic
- 700 1_
- $a Parackova, Tereza $u Department of Oncology, University Hospital Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic
- 700 1_
- $a Resova, Kamila $u Department of Oncology, University Hospital Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic
- 773 0_
- $w MED00165460 $t Radiation oncology (London, England) $x 1748-717X $g Roč. 16, č. 1 (2021), s. 235
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34876173 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130746 $b ABA008
- 999 __
- $a ok $b bmc $g 1789367 $s 1162934
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 16 $c 1 $d 235 $e 20211207 $i 1748-717X $m Radiation oncology $n Radiat. oncol. $x MED00165460
- GRA __
- $a FNOs/2021 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a FNOs/2021 $p Ministerstvo Zdravotnictví Ceské Republiky
- LZP __
- $a Pubmed-20220425